Tumores del Estroma Gastro Intestinal
Este video titulado "Tumores del Estroma Gastro Intestinal" fue creado por la Fundación GIST México para el Día de Concienciación GIST 2020.
Fisiopatología de GIST
El equipo de voluntarios de la Fundación se dio a la tarea de desarrollar este increible video que nos explica sobre la formación de un tumor del estroma gastrointestinal.
GIST Awareness Day 2020 – Spain
Colectivo GIST Espańa celebró el Día de Concienciación de GIST (GIST Awareness Day) con una publicación sobre el tema. A pesar de todo el trabajo realizado por las asociaciones de pacientes, por los [...]
GIST Awareness Day 2020 – Mexico
Fundación GIST México celebrated GIST Awareness Day with these actitivities: Spot on local radio. "GISTJuntos" This spot which was broadcast 4 times a day from July 8th to [...]
GIST Awareness Day 2020 – UK
GIST Cancer UK celebrated GIST Awareness Day by sharing stories of patient and clinicians. GIST Awareness Day was created by the Life Raft Group in 2014 to bring awareness and public attention to gastrointestinal stromal tumors and raise funds for #GISTresearch.
GIST Awareness Day 2020 – Chile
GIST Chile celebrated GIST Awareness Day 2020 with the themes #GISTHope and #GISTJuntos (GIST Together). You can find GIST Chile on Facebook - https://www.facebook.com/gistchile, Twitter - @GistChile, Insta - gist_chile. GIST Awareness Day was [...]
GIST Awareness Day 2020 – India
Friends of Max (FOM), led by Viji Venkatesh, enthusiastically celebrated GIST Awareness Day 2020 with a plethora of posts and patient stories as well as patient meetings.
GIST Awareness Day 2020 – Hungary
András Szekfü, of Budapest, Hungary, shares his GIST journey in this video for GIST Awareness Day, a day set aside to bring awareness of this disease.
Making the Right Decisions in Tough Times
Amelia Yeo, LRG Country Liaison for Singapore and GIST caregiver, describes how she and her husband are doing during this global health pandemic.
QINLOCK (ripretinib) – aprobado como cuarta línea de tratamiento para GIST
La FDA aprobó QINLOCKTM (ripretinib) para el tratamiento de adultos con tumor avanzado del estroma gastrointestinal (GIST) que han recibido 3 o más tratamientos previos para su GIST.